To investigate the role of p53 inhibitor pifithrin-α in glycerol-induced rhabdomyolysis and AKI, the renal morphological damage and potential pathogenic pathway were determined in each group (Figure 3(C)). The gene discussed is TP53; the disease is rhabdomyolysis.